Home

Tai Sandi See, Chief Development Officer: Lexeo Therapeutics LXEO Sell · Filed 25/05/20

Trade details

Type
Insider sale
Amount
$1,016.59
Shares · price
367 sh · $2.77 a share
Held after
59,242 sh
Trade date
25/05/16
Filed
25/05/20
Days to filing
4 days

Sold 0.6% of holdings

Share of holding sold
0.6%

Lexeo Therapeutics trades, last 26 weeks

What else happened in Lexeo Therapeutics around then

Filed or reported within 30 days of the trade day · 25/04/16~25/06/15

Tai Sandi See's recent trades

  • Tai Sandi See

    Planned saleLexeo Therapeutics

    $24.7K

    Filed 02/18

  • Tai Sandi See

    SellLexeo Therapeutics

    $3,578

    Filed 25/11/20

  • Tai Sandi See

    Planned saleLexeo Therapeutics

    $3,580

    Filed 25/11/18

  • Tai Sandi See

    SellLexeo Therapeutics

    $34.4K

    Filed 25/10/17

  • Tai Sandi See

    SellLexeo Therapeutics

    $421

    Filed 25/10/17

Tai Sandi See, Chief Officer — sold $1,017 of Lexeo Therapeutics LXEO · 0.6% of holdings | Whalegun